Interferon-alfa2b and ribavirin combination therapy in liver transplant recipients with recurrent hepatitis C.

被引：0
|
作者：
Shakil, AO
McGuire, B
Crippin, JS
Canjeevaram, HS
Teperman, L
Gish, RG
Kwo, P
Wright, TL
Brass, C
Balan, V
Demetris, J
Rakela, J
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Univ Alabama, Birmingham, AL USA
[3] Baylor Univ, Dallas, TX USA
[4] Univ Chicago, Chicago, IL 60637 USA
[5] New York Med Ctr, New York, NY USA
[6] Calif Pacific Med Ctr, San Francisco, CA USA
[7] Indiana Univ, Indianapolis, IN 46204 USA
[8] Univ Calif San Francisco, San Francisco, CA 94143 USA
[9] Integrated Therapeut Grp Inc, Kenilworth, NJ USA
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
221
引用
收藏
页码：216A / 216A
页数：1
相关论文
共 50 条
  • [1] Interferon-alfa2B and ribavirin combination therapy in liver transplant recipients with recurrent hepatitis C.
    Shakil, AO
    Rakela, J
    HEPATOLOGY, 1999, 30 (04) : 656A - 656A
  • [2] Interferon alfa and ribavirin for orthotopic liver transplant recipients with recurrent hepatitis C.
    Firpi, RJ
    Abdelmalek, MF
    Lauwers, GY
    Nelson, DR
    GASTROENTEROLOGY, 2000, 118 (04) : A1018 - A1018
  • [3] Combination of interferon alfa 2b and ribavirin in liver transplant recipients with histologic recurrent hepatitis C
    Firpi, RJ
    Nelson, DR
    Soldevila, C
    Abdelmalek, MF
    Reed, A
    Hemming, A
    Howard, R
    Van der Werk, W
    Lauwers, G
    Davis, GL
    GASTROENTEROLOGY, 2001, 120 (05) : A93 - A93
  • [4] Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C
    Firpi, RJ
    Abdelmalek, ME
    Soldevila-Pico, C
    Reed, A
    Hemming, A
    Howard, R
    Van der Werf, W
    Lauwers, G
    Liu, C
    Crawford, JM
    Davis, GL
    Nelson, DR
    LIVER TRANSPLANTATION, 2002, 8 (11) : 1000 - 1006
  • [5] A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C
    Shakil, AO
    McGuire, B
    Crippin, J
    Teperman, L
    Demetris, AJ
    Conjeevaram, H
    Gish, R
    Kwo, P
    Balan, V
    Wright, TL
    Brass, C
    Rakela, J
    HEPATOLOGY, 2002, 36 (05) : 1253 - 1258
  • [6] Treatment with combination peginterferon alfa-2b and ribavirin of recurrent hepatitis C in liver transplant recipients nonresponsive to interferon alfa-2b and ribavirin
    Samanta, A
    Mandalapu, A
    Fisher, A
    Wilson, D
    de la Torre, A
    Klein, KM
    Koneru, B
    GASTROENTEROLOGY, 2005, 128 (04) : A455 - A456
  • [7] Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy
    Neff, GW
    Montalbano, M
    O'Brien, CB
    Nishida, S
    Safdar, K
    Bejarano, PA
    Khaled, AS
    Ruiz, P
    Slapak-Green, G
    Lee, M
    Nery, J
    De Medina, M
    Tzakis, A
    Schiff, ER
    TRANSPLANTATION, 2004, 78 (09) : 1303 - 1307
  • [8] Impact of pegylated interferon alfa-2b and ribavirin on depression in liver transplant recipients with recurrent hepatitis C
    Challis, M
    Rogge, J
    Weaver, L
    Mukherjee, S
    GASTROENTEROLOGY, 2004, 126 (04) : A699 - A699
  • [9] Interferon-alfa2b in combination with ribavirin for the treatment of chronic hepatitis C in children.
    Gonzalez-Peralta, R
    Haber, BA
    Jonas, M
    Martin, S
    Lang, T
    Geffner, M
    Albrecht, J
    HEPATOLOGY, 2002, 36 (04) : 311A - 311A
  • [10] Preemptive therapy with combination of interferon and ribavirin in liver transplant recipients with hepatitis C
    Dono, Keizo
    Marubashi, Shigeru
    Kobayashi, Shogo
    Nagano, Hiroaki
    Monden, Morito
    TRANSPLANT INTERNATIONAL, 2007, 20 : 290 - 290
12345